0000875320-24-000002.txt : 20240104 0000875320-24-000002.hdr.sgml : 20240104 20240104161723 ACCESSION NUMBER: 0000875320-24-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240102 FILED AS OF DATE: 20240104 DATE AS OF CHANGE: 20240104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WAGNER CHARLES F JR CENTRAL INDEX KEY: 0001223348 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 24512144 MAIL ADDRESS: STREET 1: C/O MILLIPORE CORP CITY: BILLERICA STATE: MA ZIP: 01820 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 wk-form4_1704403018.xml FORM 4 X0508 4 2024-01-02 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001223348 WAGNER CHARLES F JR C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP & Chief Financial Officer 1 Common Stock 2024-01-02 4 S 0 3000 405 D 43693 D Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 08/18/2023. /s/ Christiana Stevenson, Attorney-in-Fact 2024-01-04